duloxetine 40 MG Delayed Release Oral Capsule

1 INDICATIONS AND USAGE Duloxetine delayed-release capsules are indicated for the treatment of: Major depressive disorder in adults Generalized anxiety disorder in adults and pediatric patients 7 years of age and older Diabetic peripheral neuropathic pain in adults Fibromyalgia in adults Chronic musculoskeletal pain in adults Duloxetine delayed-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: Major depressive disorder (MDD) in adults ( 1 ) Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older ( 1 ) Diabetic peripheral neuropathic pain (DPNP) in adults ( 1 ) Fibromyalgia (FM) in adults ( 1 ) Chronic musculoskeletal pain in adults ( 1 )

bluepoint laboratories

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] nausea` `[4] off label use` `[5] headache` `[6] pain` `[7] diarrhoea` `[8] arthralgia` `[9] dizziness` `[10] dyspnoea`

5 years ago

CAPSULE ORANGE B 750

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Duloxetine delayed-release capsules, USP are available in the following strengths, colors, imprints, and presentations: Features Strengths 40 mg Body color Opaque orange Cap color Opaque blue Cap imprint B Body imprint 750 Presentations and NDC Codes Bottles of 30 68001-368-04 16.2 Storage and Handling Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].

More pills like CAPSULE B 750

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

duloxetine 40 MG Delayed Release Oral Capsule

FDA Reported Adverse Reactions [1] drug ineffective [2] fatigue [3] nausea [4] off label use [5] headache [6] pain [7] diarrhoea [8] arthralgia [9] dizziness [10] dyspnoea

CAPSULE ORANGE B 750

More pills like CAPSULE B 750

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] nausea` `[4] off label use` `[5] headache` `[6] pain` `[7] diarrhoea` `[8] arthralgia` `[9] dizziness` `[10] dyspnoea`